For the Inventor, By the Inventor

Enter inventor name

Rancho Santa Fe, CA, United States of America

Nikolay Filippovich Savchuk

USPTO Granted Patents = 16 (Patent Applications = 22)

EPO Patents = 2 (Patent Applications = 8)

Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 50(Granted Patents)

Location History:

Rancho Santa Fe, CA (2013)
Moscow, RU (2017)
Rancho Santa Fe, CA (US) (2012 - 2023)

Company Filing History:

Avincuro Pharmaceuticals, Inc.

4. 13 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2012-2023

Loading Chart...

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11648300 - Pharmaceutical combination therapy and prevention with aprotinin + nirmatrelvir of SARS-CoV-2 and/or disease associated with this infection, including COVID-19 (2023-05-16),

2. 10266558 - Macroheterocyclic nucleoside derivatives and their analogues, production and use thereof (2019-04-23),

3. 9655886 - Substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles, methods for use thereof (2017-05-23),

4. 8829009 - [object Object] (2014-09-09),

5. 8629154 - Substituted cycloalcano[e and d] pyrazolo [1,5-a]pyrimidines/antagonists of serotonin 5-HT6 receptors and methods for production and the use thereof (2014-01-14),

6. 8618114 - Substituted 3-arylsulfonyl-pyrazolo[1,5-A]pyrimidines, serotonin 5-HT6 receptor antagonists and methods for the production and use thereof (2013-12-31),

7. 8569318 - Tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidines as antagonists of serotonin 5-HT6 receptors, methods for the production and use thereof (2013-10-29),

8. 8552017 - 2-amino-3-sulphonyl-tetrahydro-pyrazolo[1,5-A]pyrido-pyrimidine antagonists of serotonin 5-HT6 receptors, methods for the production and use thereof (2013-10-08),

9. 8552005 - [object Object] (2013-10-08),

10. 8541437 - Substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles, methods for the production and use thereof (2013-09-24),

11. 8486945 - Heterocyclic inhibitors of an Hh-signal cascade, medicinal compositions based thereon and methods for treating diseases caused by the aberrant activity of an Hh-signal system (2013-07-16),

12. 8486936 - Antagonist of smoothened (2013-07-16),

13. 8481587 - Substituted 2-(5-hydroxy-2-methyl-1H-indole-3-yl)acetic acids and ethers thereof and the use of same to treat viral diseases (2013-07-09),

14. 8471009 - (EN) 2-alkylamino-3-arylsulfonyl-cycloalcano [e OR d] pyrazolo [1,5-A]pyrimidines / antagonists of serotonin 5-HT6 receptors, methods for the production and the use thereof (2013-06-25),

15. 8329689 - Substituted indoles and a method for the production and use thereof (2012-12-11),

Title: Innovations of Nikolay Filippovich Savchuk

Introduction

Nikolay Filippovich Savchuk is a prominent inventor based in Rancho Santa Fe, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapies for viral infections. With a total of 16 patents, his work has garnered attention for its potential impact on public health.

Latest Patents

Savchuk's latest patents include a groundbreaking pharmaceutical combination therapy aimed at the prevention and treatment of SARS-CoV-2 and related diseases, including COVID-19. This innovative therapy utilizes aprotinin, ribavirin, and nirmatrelvir to combat the virus and associated complications such as pneumonia. Another notable patent involves macroheterocyclic nucleoside derivatives and their analogues, which have been recognized for their potential as chemotherapeutic agents in treating viral infections and cancer.

Career Highlights

Throughout his career, Savchuk has worked with various companies, including Alla Chem, LLC. His research has focused on the development of nucleosides and nucleotides, which have been essential in clinical treatments for nearly five decades. His contributions to the pharmaceutical field have positioned him as a key figure in the ongoing fight against viral diseases.

Collaborations

Savchuk has collaborated with notable individuals in his field, including Andrey Alexandrovich Ivashchenko and Alexander Vasilievich Ivashchenko. These partnerships have facilitated the advancement of his research and the successful development of innovative therapies.

Conclusion

Nikolay Filippovich Savchuk's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and research continue to pave the way for new treatments that could significantly improve health outcomes for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…